Jacek Legutko

Showing 1-8 of 8 articles

Author Taku Asano

Coronary interventions

Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study

Asano T, Kogame N, Onuma Y, Modolo R, Chichareon P, Lefèvre T, Legutko J, Digne F, Morel M-A, Serruys P, Gil R

September 24, 2019 | 10.4244/EIJ-D-19-00361

Author Janusz Kochman

First serial optical coherence tomography assessment at baseline, 12 and 24 months in STEMI patients treated with the second-generation Absorb bioresorbable vascular scaffold

Kochman J, Kołtowski Ł, Tomaniak M, Jąkała J, Proniewska K, Legutko J, Roleder T, Piertrasik A, Rdzanek A, Kochman W, Brugaletta S, Opolski G, Regar E

April 6, 2018 | 10.4244/EIJ-D-17-00311

Author Zbigniew Siudak

Coronary interventions

Reduced periprocedural mortality and bleeding rates of radial approach in ST-segment elevation myocardial infarction. Propensity score analysis of data from the ORPKI Polish National Registry

Siudak Z, Tokarek T, Dziewierz A, Wysocki T, Wiktorowicz A, Legutko J, Zmudka K, Dudek D

September 20, 2017 | 10.4244/EIJ-D-17-00078

Author Jacek Legutko

Coronary interventions

Poland: coronary and structural heart interventions from 2010 to 2015

Legutko J, Siudak Z, Parma R, Ochała A, Dudek D

May 15, 2017 | 10.4244/EIJ-D-16-00836

Author Jacek Legutko

Coronary interventions

IVUS in bifurcation stenting: what have we learned?

Legutko J, Yamawaki M, Costa R, Costa M

May 19, 2015 | 10.4244/EIJV11SVA12

Author Dariusz Dudek

Mesh covered stent in ST-segment elevation myocardial infarction

Dudek D, Dziewierz A, Rzeszutko L, Legutko J, Dobrowolski W, Rakowski T, Bartus S, Dragan J, Klecha A, Lansky A, Siudak Z, Zmudka K

November 15, 2010

Author Dariusz Dudek

Time-to-reperfusion therapy influences outcome of patients with myocardial infarction subjected to facilitated PCI

Dudek D, Dziewierz A, Rakowski T, El Masri N, Sorysz D, Zalewski J, Legutko J, Zmudka K, Piwowarska W, Dubiel J

November 20, 2005

Author Dariusz Dudek

Effect of early statin and selective cyclooxygenase-2 inhibitor therapy on C-reactive protein level after percutaneous coronary angioplasty in unstable angina

Dudek D, Heba G, Legutko J, Chyrchel M, Rakowski T, Kaluza G, Dubiel J

November 20, 2005

1

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

Discover 5 new trials: GALILEO, CONDI-2/ERIC-PCI, EVOLUTE II-5 years, SCOPE and Excel 5 years

(The Trials book is supported by Biotronik)

December 13, 2019

New this week: A Dose-response Meta Analysis, stroke after MitraClip and more

December 10, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: EXTREME Study, Stent Optimization and more

December 3, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke